Ernest Mario - Net Worth and Insider Trading

Ernest Mario Net Worth

The estimated net worth of Ernest Mario is at least $14 Million dollars as of 2024-03-28. Ernest Mario is the Director of Celgene Corp and owns about 60,237 shares of Celgene Corp (CELG) stock worth over $7 Million. Ernest Mario is the Director of Boston Scientific Corp and owns about 86,032 shares of Boston Scientific Corp (BSX) stock worth over $6 Million. Ernest Mario is also the Director of Kindred Biosciences Inc and owns about 99,583 shares of Kindred Biosciences Inc (KIN) stock worth over $921,143. Besides these, Ernest Mario also holds XenoPort Inc (XNPT) , Eyenovia Inc (EYEN) , Chimerix Inc (CMRX) , VIVUS Inc (VVUSQ) , Tonix Pharmaceuticals Holding Corp (TNXP) . Details can be seen in Ernest Mario's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ernest Mario has not made any transactions after 2020-03-24 and currently still holds the listed stock(s).

Transaction Summary of Ernest Mario

To

Ernest Mario Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ernest Mario owns 11 companies in total, including Eyenovia Inc () , Soleno Therapeutics Inc () , and Kindred Biosciences Inc () among others .

Click here to see the complete history of Ernest Mario’s form 4 insider trades.

Insider Ownership Summary of Ernest Mario

Ticker Comapny Transaction Date Type of Owner
Eyenovia Inc 2020-09-11 director
Soleno Therapeutics Inc 2015-08-11 director & 10 percent owner
Kindred Biosciences Inc 2020-01-17 director
Amplitude Healthcare Acquisition Corp 2019-11-19 director
Tonix Pharmaceuticals Holding Corp 2018-06-25 director
Chimerix Inc 2018-05-18 director
Boston Scientific Corp 2015-11-16 director
XenoPort Inc 2015-05-19 director
VIVUS Inc 2013-05-29 director
Alexza Pharmaceuticals Inc 2007-07-18 director
Jasper Therapeutics Inc 2019-11-19 director

Ernest Mario Latest Holdings Summary

Ernest Mario currently owns a total of 8 stocks. Among these stocks, Ernest Mario owns 60,237 shares of Celgene Corp (CELG) as of February 12, 2019, with a value of $7 Million and a weighting of 45.33%. Ernest Mario owns 86,032 shares of Boston Scientific Corp (BSX) as of November 16, 2015, with a value of $6 Million and a weighting of 41.05%. Ernest Mario also owns 99,583 shares of Kindred Biosciences Inc (KIN) as of March 15, 2016, with a value of $921,143 and a weighting of 6.4%. The other 5 stocks XenoPort Inc (XNPT) , Eyenovia Inc (EYEN) , Chimerix Inc (CMRX) , VIVUS Inc (VVUSQ) , Tonix Pharmaceuticals Holding Corp (TNXP) have a combined weighting of 7.22% among all his current holdings.

Latest Holdings of Ernest Mario

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CELG Celgene Corp 2019-02-12 60,237 108.24 6,520,053
BSX Boston Scientific Corp 2015-11-16 86,032 68.62 5,903,516
KIN Kindred Biosciences Inc 2016-03-15 99,583 9.25 921,143
XNPT XenoPort Inc 2014-05-23 83,750 7.07 592,113
EYEN Eyenovia Inc 2020-03-24 327,239 0.99 322,789
CMRX Chimerix Inc 2018-05-18 121,072 1.01 122,283
VVUSQ VIVUS Inc 2013-05-29 8,113 0.12 952
TNXP Tonix Pharmaceuticals Holding Corp 2018-06-25 2 0.32 1

Holding Weightings of Ernest Mario


Ernest Mario Form 4 Trading Tracker

According to the SEC Form 4 filings, Ernest Mario has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the acquisition of 2,000 shares on February 12, 2019, which cost Ernest Mario around $179,980.

According to the SEC Form 4 filings, Ernest Mario has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 125,000 shares on November 16, 2015, which brought Ernest Mario around $2 Million.

According to the SEC Form 4 filings, Ernest Mario has made a total of 0 transactions in Kindred Biosciences Inc (KIN) over the past 5 years. The most-recent trade in Kindred Biosciences Inc is the acquisition of 30,000 shares on March 15, 2016, which cost Ernest Mario around $106,500.

More details on Ernest Mario's insider transactions can be found in the Insider Trading History of Ernest Mario table.

Insider Trading History of Ernest Mario

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ernest Mario Trading Performance

GuruFocus tracks the stock performance after each of Ernest Mario's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ernest Mario is 3.22%. GuruFocus also compares Ernest Mario's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ernest Mario within 3 months outperforms 35 times out of 68 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ernest Mario's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ernest Mario

Average Relative Return

3.61%

Average relative return per transaction

Outperforming Transactions

52%

35 out of 67 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 4.82 3.22 -2.26 3.61 -1.1 -13.58
Relative Return to S&P 500(%) 4.47 0.36 -7.34 -9.01 -13.98 -25.56

Ernest Mario Ownership Network

Ownership Network List of Ernest Mario

No Data

Ownership Network Relation of Ernest Mario


Ernest Mario Owned Company Details

What does Eyenovia Inc do?

Who are the key executives at Eyenovia Inc?

Ernest Mario is the director of Eyenovia Inc. Other key executives at Eyenovia Inc include 10 percent owner Stuart M. Grant , director & Chief Executive Officer Michael M Rowe , and Chief Financial Officer John P Gandolfo .

Eyenovia Inc () Insider Trades Summary

Over the past 18 months, Ernest Mario made no insider transaction in Eyenovia Inc (). Other recent insider transactions involving Eyenovia Inc () include a net sale of 270,000 shares made by Tsontcho Ianchulev , a net purchase of 245,717 shares made by Stuart M. Grant , and a net purchase of 17,427 shares made by Michael M Rowe .

In summary, during the past 3 months, insiders sold 0 shares of Eyenovia Inc () in total and bought 60,717 shares, with a net purchase of 60,717 shares. During the past 18 months, 270,000 shares of Eyenovia Inc () were sold and 289,464 shares were bought by its insiders, resulting in a net purchase of 19,464 shares.

Eyenovia Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eyenovia Inc Insider Transactions

No Available Data

Ernest Mario Mailing Address

Above is the net worth, insider trading, and ownership report for Ernest Mario. You might contact Ernest Mario via mailing address: 20 Fairmount Avenue, P.o. Box 445, Chatham Nj 07928.

Discussions on Ernest Mario

No discussions yet.